Igenomix Middle East +971 4 5519465

Corporate news

With the aim to disseminate knowledge about the advancement in the field of reproductive science and medicine, Igenomix’s team of experts will be present at the annual meet of MEFS […]

leer mas

We are proud to announce our wide participation at this year ESHRE annual meeting in Geneva, Switzerland from July 2nd – July 5th, 2017. Find out the full program here.

leer mas

This year’s Human Reproduction keynote lecture, which will open ESHRE’s Annual Meeting in Geneva, will be given by our CSO Prof. Carlos Simón, who will address one of the biggest audiences […]

leer mas

IGENOMIX at ESHRE 2017 From 2 – 5 July at Palexpo venue, Geneva, Switzerland. IGENOMIX will be taking part in this year’s ESHRE Annual Meeting, held at the Palexpo venue […]

leer mas

We are proud to announce that our product autologous adult bone marrow-derived non-expanded CD133+ haematopoietic stem cells (IGX1) was granted the Orphan Drug Designation (ODD) on March 15th 2017 by […]

leer mas

Igenomix has achieved yet another milestone in the field of advanced reproductive genetics in Middle East after being honored with Frost & Sullivan Best Practices Awards. This Global program recognizes outstanding […]

leer mas

The conference mainly aims at the education of the medical community and dissemination of reliable information to at-risk populations. IGENOMIX hope to inherit the outstanding tradition of the UEARS and […]

leer mas

Consanguinity is a deeply rooted social trend among one-fifth of the world population. Around the globe consanguineous marriages (Commonly known as “Cousin Marriages”) is in practice by many societies from […]

leer mas
18 January, 2017

Igenomix will be present at Emirates Obstetrics Gynaecology & Fertility Forum on 19th-21st January 2017, at Al Bustan Rotana Hotel, Dubai. IGENOMIX is a company that provides advanced services in […]

leer mas

Most women opting for assisted methods of achieving pregnancy have a lot of questions regarding the success of these procedures. And those who have already gone through the procedure multiple […]

leer mas